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Abstract
This study was conducted to investigate the effect of dietary soluble fiber administration and /or high fat diet on serum and brain neurohormonal 
profiles, adipose tissue mass and body weight gain in Sprague-Dawley rats. Four groups of rats were respectively fed 10% fat diet (C), 10% fat
plus pectin diet (P), 20% fat diet (HFC) and 20% fat plus pectin diet (HFP) for 4 weeks. In HFP group, the food and energy intake, body weight
gain, FER including fecal excretion were the smallest (p<0.05). Serum HDL-cholesterol, triglyceride and glucose level were also the lowest in HFP
group (p<0.05). The weight of brain, epididymal fat pad and adrenal gland except liver didn’t show any significant differences among groups. Interestingly
serum norepinephrine concentration of HFP group tended to be higher, but dopamine concentration tended to be lower than those of HFC group.
However serum catecholamine concentration didn’t show any significant differences among all groups. Norepinephrine and epinephrine contents
of right portion of midbrain of P and HFP groups were remarkably lower than those of the C group. These results suggested that soluble fiber 
pectin consumption might affect neurohormonal profiles in serum and brain according to dietary fat level.
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Introduction8)
Obesity is considered to result from the imbalance between 
energy intake and energy expenditure. Reducing food intake, 
altering metabolism and/or increasing energy expenditure will be 
used for treating obesity. In general, weight control medication 
is done with appetite suppressants, lipolysis stimulant and ther-
mogenesis inducer. Their anorectic effects are considered to 
induce the efficacy via brain monoamines, especially nora-
drenergic or serotonergic neurotransmission. The effectiveness of 
some medications is supposed to work only when they are used 
and to have addictive properties probably related to the dopa-
minergic neurotransmission. Moreover, it was reported that most 
medications were not reached even the level of expected 15% 
weight loss, compared to 30% weight loss by gastric-bypass 
surgery (Bray, 2001). Recently alternative/complementary func-
tional foods for antiobesity are available for many therapeutic 
herbs containing phytochemicals which have far fewer side 
effects in comparison to pharmaceutical agents. But much caution 
is needed to use them because many of them are produced 
without proper quality control and standardization. 
It is known that a realistic goal of weight loss is to reduce 
current weight by 5 to 10% which improves the overall health 
(NIH, 2000). Most reasonable and safest weight loss strategy is 
choosing nutritious foods in moderation and increasing expend-
iture by daily physical activity. Aside from their lower energy 
densities, food such as whole grain, legumes, nuts, fruits, and 
vegetables offer many micronutrients and fibers. In these foods, 
fiber tends to have great volumes, thus helping people feel full 
and satisfied. The expansion of stomach in response to the food 
volume provides a powerful satiety signal, which relays the 
information to the brain via neural system, inhibiting further 
intake of food. Nutritionists recommend consuming dietary fiber, 
nutrient as well as phytochemicals, 5-6 times per day as possible 
to prevent obesity, cancer, cardiovascular disease and diabetes 
mellitus. Dietary fibers are indigestible because of their beta- 
glycosidic bonds, but are fermentable by bacteria in the intestine. 
Insoluble fiber increases stool weight and fecal volume and in 
turn stimulates peristaltic contraction of the colon, propelling the 
material forward and helping to prevent and alleviate const-
ipation. These intestinal contraction and movement are controlled 
by parasympathetic nervous system (Martini et al., 1995). On 
the other hand, soluble fiber has water-holding capacities and 
binding capacity of cholesterol-containing bile to inhibit entero-
hepatic circulation. Normalizing blood glucose and cholesterol 
levels, it is important for people at risk for diabetes and/or cardio-
vascular disease (Mcguire et al., 2007). In fact, these metabolic 
diseases are closely related to the obesity, and there is an 
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Table 1. The experimental diet
1) (g/kg diet)
Groups
Components
10% fat diet 20% fat diet
CP H F C H F P
Casein
Corn oil
Corn Starch
Dextrose
Mineral mixture
2)
Vitamin mixture
3)
Choline bitartrate
t-Butylhydroquinone
L-cystine
Fiber
Cellulose
Pectin
Total
150
100
594.486
50
40
10
2.5
0.014
3
50
0
1,000
150
100
594.486
50
40
10
2.5
0.014
3
25
25
1,000
150
200
494.486
50
40
10
2.5
0.014
3
50
0
1,000
150
200
494.486
50
40
10
2.5
0.014
3
25
25
1,000
1)  Diets  were  modified  AIN  76  diet  and  given  in  powered  form.
2)  AIN  76  mineral  mixture 
3)  AIN  76  vitamin  mixture
C group 10% fat  &  5% cellulose  /  kg  diet 
P g r o u p 1 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
HFC group 20% fat  &  5% cellulose  /  kg  diet
H F P g r o u p 2 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
attractive hypothesis that a defect may exist in controlling the 
mobilization of lipids from fat depots of obese subjects. Lipolysis 
is under intense hormonal control. In human, catecholamines play 
a major role as they are the only hormone with a pronounced 
and acute lipolytic effect in adipose tissue of adult subjects. 
Lipolysis in human fat cells can be stimulated by catecholamine 
through  β1-and  β2- adrenoreceptors and inhibited through α2- 
adrenoreceptors (Reynisdottir et al., 1994). 
Pectin, soluble dietary fiber, is one of the plant polysaccharide 
in the apple skin or herb like ginseng. In Korea, apple is usually 
consumed for not only favorite fruit but also weight control of 
female and ginseng is ergogenic aids for athletes and male adults. 
It was speculated that lipolysis might be related to the efficacy 
of both foods. Would dietary fiber induce to release neurohor-
mone such as norepinephrine centrally or peripherally? This 
study was conducted to investigate pectin administration and /or 
high fat diet on catecholamine profiles in serum and brain of 
Sprague-Dawley rats. 
Materials and Methods
Animals and diets
Male, 3-wk-old Sprague-Dawley rats (n=28, average initial 
weight 61.4±2.2g) were obtained from Animals Co. (Daehan, 
Korea). After three days of acclimatization, rats were divided 
into four groups which were respectively given 10% fat diet (C) 
as control group, 10% fat plus pectin diet (P), 20% fat diet (HFC) 
and 20% fat plus pectin diet (HFP) for four weeks. The diets 
were the modified AIN 76 diet (Reeves et al., 1993). For dietary 
fiber source, 5% cellulose was administered in C and HFC diets, 
and 2.5% cellulose plus 2.5% pectin were added in P and HFP 
diets (Table 1). All ingredients for diet were purchased from 
Labanimal Co. (Dyets, Bethleham, PA). The animals were housed 
individually in stainless steel wire-bottom cage in an auto-
matically light controlled (06:00-18:00h) and temperature con-
trolled (20-22℃) room with relative humidity (50-60%). They 
were fed each diet and tap water ad libitum. Food intake was 
recorded daily and the body weight was recorded weekly. Feces 
were collected weekly. From the food Intake, energy intake and 
body weight gain of rats, food efficiency ratio (FER) and energy 
efficiency ratio (EER) were calculated. After 4 weeks of feeding, 
the animals were anesthetized with ethyl ether and blood from 
the carotid and the tissue samples were collected. Blood samples 
were stored in the refrigerator overnight and centrifuged at 
3,000rpm for 20 min. Serum was stored at -70℃ until analysis. 
All animal procedures conformed to “Guide for the Care and 
Use of Laboratory Animals” (National Research Council, 1996). 
On the ice, the brain was removed immediately after sacrificing 
the animals. Frontal, parietal, and temporal portions of forebrain 
and left/right portions of midbrain of rats were stored in 1% 
perchloric acid at -70℃ until analysis. The weight of brain, liver, 
adrenal gland and epididymal fat pad were recorded. 
Biochemical analysis
The serum and brain norepinephrine, epinephrine and dopa-
mine were analyzed with a HPLC system, consisted of pump 
(Model 930, Younglin, Anyang, Korea), electrochemical detector 
(464 pulsed ECD, Waters, USA) and Nova-Pak C18 (3.9×150 
mm, Waters, USA). Brain homogenates were centrifuged at 
15,000rpm at 4℃ for 10 min and supernatants were filtered and 
injected onto HPLC column immediately. Serum norepinephrine, 
epinephrine and dopamine purified by an alumina extraction was 
quantitated by ECD detection (Pesce & Kapla, 1987). Mobile 
phase was composed with 0.15mM chloroacetic acid, 250mg Na2 
EDTA, 80mg octylsulfate in 1L of distilled water with 5% 
methanol (pH 3.5), and flow rate of mobile phase was 1.0ml/min 
(Morier-Teissier  et al., 1984). All reagents for analysis and 
standard reagents used were the product of Sigma Co. (St. Louis, 
USA). The total- and HDL-cholesterol, triglyceride and glucose 
in serum were determined enzymatically by using a commercial 
kit (Asan Pharmaceutical, Seoul Korea). Serum LDL-cholesterol 
was calculated from the equation of Friedewald et al. (1972). 
The fecal lipid excretion was measured using the method of Bligh 
et al. (1959). 
Statistical analysis
The data were expressed as means±standard deviation. Data 
were evaluated through two-way ANOVA to test for main effects 
of dietary fat level and pectin administration at a=0.05 level. 
The significance of difference between groups was analyzed by 
one-way analysis of variance (ANOVA) and Duncan’s multiple Dongsoon Shin 293
Table 2. Food Intake, energy intake, body weight gain and organ weight of experimental rats
Groups
Variables
10% fat diet 20% fat diet
Significant factor
5)
CP H F C H F P
Food intakes (g/d)
Energy intakes (kcal/d)
Body weight (g)
initial
final
Body weight gain (g/d)
FER
3)
EER
4)
Organ weight (g)
brain
epididymal fat
liver
adrenal gland
15.89 ± 0.75
1)a2)
65.14 ± 3.78
a
 61.7 ± 2.7
228.3 ± 14.4
a
 5.95 ± 0.44
a
0.374 ± 0.023
ab
0.091 ± 0.056
ab
 1.24 ± 0.08
 2.17 ± 0.72
 9.61 ± 2.09
a
 0.18 ± 0.21
15.21 ± 0.92
a
63.70 ± 3.31
a
 61.7 ± 1.6
233.3 ± 15.2
a
 6.14 ± 0.53
a
0.411 ± 0.019
a
0.089 ± 0.042
a
 1.21 ± 0.16
 1.84 ± 1.13
 9.99 ± 1.86
a
 0.23 ± 0.25
13.85 ± 0.63
b
62.36 ± 3.78
ab
 61.7 ± 1.8
220.7 ± 6.4
a
 5.68 ± 0.19
a
0.403 ± 0.014
ab
0.098 ± 0.035
a
 1.31 ± 0.11
 1.94 ± 0.70
 9.74 ± 0.89
a
 0.08 ± 0.02
12.69 ± 0.59
c
58.39 ± 3.78
b 
 61.2 ± 2.0
N.S.
188.1 ± 23.3
b
 4.53 ± 0.80
b
0.357 ± 0.076
b
0.078 ± 0.011
b
 1.31 ± 0.09
N.S.
 1.33 ± 0.96
N.S.
 7.46 ± 1.89b
b
 0.18 ± 0.30
N.S.
B
B
B
B
B
B
B
1) M e a n  ±  S . D .
2)  Values  with  differnent  alphabet  within  row  significantly  different  at  a=0.05  level  by  Duncan's  multiple  test
3)  FER:  food  efficiency  ratio  (body  weight  gain  g  /  food  intake  g)
4)  EER:  energy  efficiency  ratio  (body  weight  gain  g  /  energy  intake  kcal)
5)  Statistical  significance  of  experimental  factor  was  calculated u s i n g  t w o - w a y  A N O V A . 
A;  effect  of  pectin  administration  was  significant  at  a=0.05  level.
B;  effect  of  dietary  fat  level  was  significant  at  a=0.05  level.
N.S.  not  significant  at  a=0.05  level  by  Duncan’s  multiple  test
C group 10% fat  &  5% cellulose  /  kg  diet 
P g r o u p 1 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
HFC group 20% fat  &  5% cellulose  /  kg  diet
H F P g r o u p 2 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
range test at the p<0.05 significance level using SPSS PC v.12 
Program. 
Results 
Food intake & body weight gain
As shown in Table 2, the food intake of rats fed 10% fat diet 
(C & P) was significantly higher than that of 20% fat diet (HFC 
& HFP) (p<0.05). Rats fed 20% fat plus pectin diet (HFP) 
consumed the lowest amount among all groups. Body weight 
gain of rats fed 20% fat plus pectin diet (HFP) was significantly 
lower (p<0.05) than that of rats fed the other diets. As a result, 
food efficiency ratio (FER) of rats fed 20% fat diet (HFC) was 
the highest, while that of rats fed 20% fat plus pectin diet (HFP) 
was the lowest (p<0.05). However, there was no significant 
difference between FER of rats fed 10% fat diet (C) and that 
of rats fed 10% fat plus pectin diet (P). 
Weight of epididymal fat mass and organs
There were no significant differences in brain, epididymal fat 
pad and adrenal gland weights of rats according to the fat level 
in diets or pectin administration, even though epididymal fat mass 
of rats fed diets with pectin (P & HFP) tended to be lower than 
that of rats fed diet without pectin (C & HFC). However, liver 
weight of rats fed 20% fat plus pectin diet (HFP) was the lowest 
significantly among all groups (Table 2). 
Fecal and serum lipids
As shown in Table 3, daily fecal excretion of rats fed diet 
with pectin (P & HFP) was significantly lower than that of rats 
fed without pectin (C & HFC). Compared with the rats fed 10% 
fat diet plus pectin diet (P), rats fed 20% fat plus pectin diet 
(HFP) excreted less feces significantly (p<0.05). There were no 
significance differences in total lipid contents per gram of feces 
among groups. However, rats fed 20% fat diet (HFC & HFP) 
tended to excrete more feces than those fed 10% fat diet (C 
& P). 
Serum total cholesterol and LDL-cholesterol did not show any 
significant differences among all groups. Unfortunately, serum 
HDL-cholesterol of rats fed 20% fat plus pectin diet (HFP) was 
significantly lower than that of rats fed 10% (C) or 20% fat 
diet (HFC). However, serum triglyceride and glucose concen-
trations of HFP group were the lowest among all groups (p<0.05). 
Catecholamine concentration of serum and brain
Generally norepinephrine contents in brain did not show any 
significant differences among the groups. However, in the right 
portion of midbrain, norepinephrine contents of rats fed 10% fat 
diet group (C) were significantly higher than those of rats fed 
the other diets (p<0.05) (Table 4). Epinephrine contents were 
not detected at all in the frontal portion of brain in all groups. 
Even though epinephrine contents were detected in the left 
midbrain, there were no significant differences. Especially dopa-
mine contents were not detected in most samples except the 
frontal portion or right portion of midbrain. 294 Dietary soluble fiber and Neurohormone
Table 3. Fecal lipid amount, serum lipid profiles and glucose concentration of experimental rats. 
Groups
Variables
10% fat diet 20% fat diet 
Significant factor
3)
CP H F C H F P
Feces
Excretion weight (g/d)
Total lipid (mg/g)
Serum
LDL- cholesterol (mg/dL)
HDL- cholesterol (mg/dL)
Total cholesterol (mg/dL) 
Triglyceride (mg/dL)
Glucose (mg/dL)
 1.14 ± 0.29
a
160.0 ± 130.0
 71.0 ± 18.9
1)
 33.6 ± 8.7
a2)
110.5 ± 15.1
 29.5 ± 19.5
a
 90.0 ± 17.5
ab
 0.88 ± 0.20
b
160.0 ± 100.0
 73.4 ± 25.7
 26.3 ± 16.6
ab
103.4 ± 11.2
 26.1 ± 14.6
ab
 85.3 ± 25.8
ab
 1.01 ± 0.01
ab
250.0 ± 130.0
 75.9 ± 17.6
 31.6 ± 11.4
a
112.2 ± 20.9
 23.7 ± 9.7
ab
 99.8 ± 23.2
a
0.51 ± 0.25
c
230.0 ± 130.0
N.S.
81.0 ± 18.1
N.S.
15.9 ± 9.2
b
99.5 ± 12.5
N.S.
13.3 ± 8.0
b
70.3 ± 20.5
b
A, B
A
A
1)  Mean ± S.D.
2)  Values  with  different  alphabet  within  row  significantly  different  at  a=0.05  level  by  Duncan’s  multiple  test
3)  Statistical  significance  of  experimental  factor  was  calculated u s i n g  t w o - w a y  A N O V A .
A;  effect  of  pectin  administration  was  significant  at  a=0.05  level.
B;  effect  of  dietary  fat  level  was  significant  at  a=0.05  level.
N.S.  not  significant  at  a=0.05  level  by  Duncan’s  multiple  test
C group 10% fat  &  5% cellulose  /  kg  diet 
P g r o u p 1 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
HFC group 20% fat  &  5% cellulose  /  kg  diet
H F P g r o u p 2 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
Table 4. Brain catecholamine contents of experimental rats. (ng/g wet brain)
Groups
Variables
10% fat diet 20% fat diet
Significant factor
3)
CP H F C H F P
Norepinephrine
   frontal portion
   parietal portion 
   temporal portion
   m i d b r a i n   l e ft
right 
Epinephrine
   frontal portion 
   parietal portion 
   temporal portion
   m i d b r a i n   l e ft
right 
Dopamine
   frontal portion 
   parietal portion 
   temporal portion
   m i d b r a i n   l e ft
right
 36.90 ± 7.96
1)
 20.46 ± 4.46
 14.12 ± 2.18
 69.92 ± 35.06
119.61 ± 52.69
a2)
－
 14.76 ± 2.63
 16.75 ± 1.71
 12.05 ± 16.37
190.74 ± 47.5
a
 14.62 ± 0.93
－
－
－
 33.16 ± 48.71
 29.88 ± 12.91
 30.28 ± 16.04
 15.38 ±  4.46
 69.19 ± 15.50
 52.98 ± 10.41
b
－
 15.34 ±  5.64
－
  9.17 ±  3.74
 80.91 ± 18.85
b
－
－
－
－
－
 33.27 ± 15.98
 23.04 ±  7.27
 
 16.15 ±  6.02
 87.63 ± 31.97
 67.97 ± 11.00
b
－
 14.10 ± 1.51
－
 11.84 ± 2.0
106.16 ± 12.83
b
－
－
－
－
  3.69 ± 0.46
 24.31 ± 6.54
N.S.
 23.75 ± 12.64
N.S.
 17.74 ± 11.79
N.S.
 89.06 ± 18.75
N.S.
 63.24 ± 16.68
b
－
 17.63 ± 9.55
N.S.
  9.71 ± 0.50
  4.42 ± 1.85
N.S.
 89.63 ± 18.55
b
－
－
－
－
  3.01 ± 0.00
 
 
 
A
A
A, B
1)  Mean ± S.D.
2)  Values  with  different  alphabet  within  row  significantly  different  at  a=0.05  level  by  Duncan’s  multiple  test.
3)  Statistical  significance  of  experimental  factor  was  calculated u s i n g  t w o - w a y  A N O V A . 
A;  effect  of  pectin  administration  was  significant  at  a=0.05  level.
B;  effect  of  dietary  fat  level  was  significant  at  a=0.05  level.
N.S.  not  significant  at  a=0.05  level  by  Duncan’s  multiple  test
C g r o u p 1 0 % f a t  &  5 % c e l lu l o s e  /   k g  d i e t 
P g r o u p 1 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
H F C g r o u p   2 0 % f a t  &  5 % c e l lu l o s e  /   k g  d i e t
H F P g r o u p 2 0 % f a t  &  2 . 5 % c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t
-  ;  not    detected
Serum norepinephrine and dopamine concentrations did not 
show any significant differences among all groups. As shown 
in Figure 1, epinephrine concentration was significantly higher 
in 10% fat diet group (C) than 20% fat diet group (HFC) reg-
ardless of pectin administration (p<0.05). In 20% fat plus pectin 
diet group (HFP), serum norepinephrine tended to be higher, but 
dopamine concentration tended to be lower compared to those 
of the other groups. The ratios of norepinephrine level versus 
epinephrine level in 20% fat diet groups (HFC & HFP) were 
twice higher than those of 10% fat diet groups (C & P). However, 
the ratio of dopamine level versus epinephrine level of 20% fat 
diet group (HFC) was three or four times higher than those of 
the other groups (Figure 2). 
In conclusion, dietary fat level significantly influenced food 
intake, body weight gain, FER, EER and liver weight, while 
pectin administration affected serum HDL-cholesterol, serum Dongsoon Shin 295
Fig. 1. Serum catecholamine concentration in experimental rats. 
(C group 10%  fat & 5%  cellulose /kg diet; P group 10%  fat & 2.5% cellulose 
+ 2.5% pectin / kg diet;  HFC  group  20%  fat & 5% cellulose / kg diet; HFP 
g r o u p    2 0 %   f a t  &  2 . 5 %   c e ll u lo s e  +  2 . 5 %  p e c t in  /  k g  d i e t ) 
Fig. 2. Serum catecholamine ratio in experimental rats
(C group  10%  fat & 5%  cellulose /kg diet; P group 10%  fat & 2.5% cellulose 
+ 2.5% pectin / kg diet;  HFC  group  20%  fat & 5% cellulose / kg diet;  HFP 
g r o u p   2 0 %   f a t  &  2 . 5 %   c e l lu l o s e  +  2 . 5 %  p e c t i n  /  k g  d ie t )
glucose, norepinephrine in the right portion of midbrain and 
epinephrine in the temporal portion of midbrain. Epinephrine in 
the right portion of midbrain and fecal excretion was significantly 
affected by both pectin administration and dietary fat level. 
Discussion
Today, one of the most popular types of diets is high fat, low 
carbohydrate diet. It is considered the main cause of metabolic 
imbalance that underlies obesity. Traditionally in Asia, most 
energy comes from carbohydrates, and fat has contributed only 
10%~20% of total energy, even though in recent times the 
percentage of dietary fat has reached 25% of total energy. 
However, high carbohydrate intake may not be entirely neutral 
with respect to chronic diseases when it is ingested for a long 
period of time (Grundy SM, 1999). The source of dietary carbo-
hydrates is an issue of some potential importance. Especially in 
non-digestible forms of carbohydrates, dietary fiber is the edible 
parts of plants that are resistant to digestion and absorption in 
the human intestine. Among dietary fibers, functional fiber has 
promoted beneficial physiological effects including laxation, 
and/or blood cholesterol attenuation, and/or glucose attenuation 
(FNB/IOM, 2002). 
Some reviews have focused on the effects of dietary suppl-
ements including the commonly consumed fibers on the human 
body weight reduction (Howarth et al., 2001; Pittler & Ernst, 
2004). They suggested that addition of 14 g/d of either soluble 
or insoluble fiber increased post-meal satiety and caused a modest 
decrease in body weight, but there is little evidence that the 
commonly available fiber supplements, such as chitosan, have 
any beneficial effects on human health. Artiss et al. (2006) 
reported that a new soluble dietary fiber, a-cyclodextrin (4%) 
induced the effect in reducing body weight gain and improving 
metabolic syndrome in 40% fat diet, that is, it elicited a reduction 
in plasma triglyceride level of 30%, total cholesterol of 9%, and 
increasing fecal lipid content as well as decreasing plasma leptin 
significantly. 
In this study, the effects of dietary soluble fiber and pectin 
on the lipid parameter in feces or serum, and neurohormone 
profiles in serum and brain were examined in rats fed diets with 
different fat contents. In 20% fat diets (HFC & HFP), pectin 
administration significantly induced the reduction of food intake, 
body weight gain and serum triglyceride and glucose level. 
However, there was an undesirable result of decreasing serum 
HDL-cholesterol significantly due to the decrease of total 
cholesterol and the increase of LDL-cholesterol even though it 
was slight. As shown in Figure 2, the ratios of norepinephrine 
level versus epinephrine level in 20% fat diet groups (HFC & 
HFP) were twice higher than those of 10% fat diet groups (C 
& P). However, the ratio of dopamine level versus epinephrine 
level of 20% fat group (HFC) was three or four times higher 
than those of the other groups. Surprisingly, serum norepine-
phrine level of HFP group was the highest, but relatively low 
in the right portion of midbrain among all groups. From these 
results, it was suggested that the smaller adipose tissue mass and 
body weight gain in rats fed with the 20% fat plus pectin diet 
might be related to serum and midbrain norepinephrine levels 
and pectin administration might regulate the catecholamine 
balance in high fat diet which relatively increased the dopamine 
level in serum.
There are only two FDA approved long-term use antiobesity 
drugs, olistat and sibutramine. The former acts to inhibit 
pancreatic lipase activity in small intestine and induce modest 
weight loss and maintenance (Heck et al., 2000). The latter is 
known to inhibit the reuptake of norepinephrine and serotonin 
which reduces body weight by suppressing appetite (Bray, 2001). 
Actually, it was reported that some food components, such as 
caffeine, can increase urine and plasma catecholamine concentra-
tion (McKevoy, 1998; Bell et al., 2001). Especially catechins 
in green tea were considered to induce thermogenic effect by 296 Dietary soluble fiber and Neurohormone
increasing the level of norepinephrine, because catechin poly-
phenols are known to inhibit catechol-O-methyltransferase, the 
enzyme that degrades norepinephrine (Cooper et al., 2005). 
Biogenic amines, small molecules made in the body from 
single amino acids, serve a number of roles as hormones, neuro-
transmitters, tissue humors, and others. Two chemical classes of 
biogenic amine act as hormones, the catecholamine and indo-
lamines. The catecholamine, primarily epinephrine and to a lesser 
extent, norepinephrine play multiple roles in humans and animals, 
depending on the species and circumstances. They are secreted 
into the bloodstream by the chromaffin cells of the adrenal 
medulla and have diverse actions as hormones on the effector 
cells. Norepinephrine occurs primarily within the nervous system, 
as a neurotransmitter rather than a hormone (Quay et al., 1995). 
When norepinephrine is injected into the brain paraventricular 
nucleus (PVN) or ventromedial nucleus (VMN) of satiated rats, 
it stimulates food intake by α2-adrenoreceptors and is preferen-
tially manifested by higher carbohydrate intake (Leibowitz, 
1986). Conversely, injection of norepinephrine into the perifor-
nical-lateral hypothalamus (LH) reduces food intake through β
-adrenoreceptor. The changes in norepinephrine in both VMH 
and LH are opposite to those which would be expected to stimu-
late food intake in either area, suggesting that they may change 
as a result of counterregulation intended to suppress food intake 
(Shimizu & Bray, 1989). Peripherally, norepinephrine and epine-
phrine stimulate α1-, and β1-adrenoreceptor and accelerate 
cellular energy utilization and mobilization of energy reserves. 
In skeletal muscle, they trigger the glycogen reserve and 
accelerate the breakdown of glucose to provide ATP. In adipose 
tissue, stored fat are broken down to fatty acids and the fatty 
acid are released into the circulation for use by other tissues, 
and in the liver, glycogen molecules are broken down into 
glucose to be released into the bloodstream, primarily for use 
by neural tissues. In the heart, stimulation of β1-adrenoreceptor 
triggers an increase in the rate and force of cardiac muscle 
contraction. In the brain, norepinephrine is distributed widely 
from cerebral cortex to brain stems, while epinephrine is found 
in thalamus, hypothalamus and midbrain, and dopamine is in 
hypothalamus and limbic system (Martini et al., 1995). It was 
not surprising that brain dopamine contents were not detected 
in samples except the right portion of midbrain in this study. 
Conclusively, it is suggested that dietary pectin consumption 
as a kind of stressor may affect norepinephrine metabolism 
diversely depending on dietary fat levels in rats. In the future, 
more researches will be necessary to investigate the change of 
neurohormone profiles in blood and brain in animals consumed 
different levels of dietary components and soluble functional fibers.
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